Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GLEASON SCORE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 178 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wilkinson, BA; Hamdy, FC
      State-of-the-art staging in prostate cancer

      BJU INTERNATIONAL
    2. Prost, J; Gros, N; Bastide, C; Bladou, F; Serment, G; Rossi, D
      Correlation between Gleason scores on prostatic biopsies and prostatectomyspecimens

      PROGRES EN UROLOGIE
    3. Okegawa, T; Noda, H; Ohta, M; Kato, M; Nutahara, K; Higashihara, E
      Use of various combinations of free, complexed and total prostate-specificantigen levels as predictors of the pathologic stage of prostate cancer

      INTERNATIONAL JOURNAL OF UROLOGY
    4. Egawa, S; Suyama, K; Arai, Y; Tsukayama, C; Matsumoto, K; Kuwao, S; Baba, S
      Treatment outcome by risk group after radical prostatectomy in Japanese men

      INTERNATIONAL JOURNAL OF UROLOGY
    5. So, MJ; Cheville, JC; Katzmann, JA; Riehle, DL; Lohse, CM; Pankratz, VS; Sebo, TJ
      Factors that influence the measurement of prostate cancer DNA ploidy and proliferation in paraffin embedded tissue evaluated by flow cytometry

      MODERN PATHOLOGY
    6. Wolf, JS
      Indications, technique, and results of laparoscopic pelvic lymphadenectomy

      JOURNAL OF ENDOUROLOGY
    7. Thurman, SA; Ramakrishna, NR; DeWeese, TL
      Radiation therapy for the treatment of locally advanced and metastatic prostate cancer

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    8. Quinn, DI; Henshall, SM; Haynes, AM; Brenner, PC; Kooner, R; Golovsky, D; Mathews, J; O'Neill, GF; Turner, JJ; Delprado, W; Finlayson, JF; Sutherland, RL; Grygiel, JJ; Stricker, PD
      Prognostic significance of pathologic features in localized prostate cancer treated with radical prostatectomy: Implications for staging systems and predictive models

      JOURNAL OF CLINICAL ONCOLOGY
    9. Egawa, S; Suyama, K; Arai, Y; Matsumoto, K; Tsukayama, C; Kuwao, S; Baba, S
      A study of pretreatment nomograms to predict pathological stage and biochemical recurrence after radical prostatectomy for clinically resectable prostate cancer in Japanese men

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    10. Thornbury, JR; Ornstein, DK; Choyke, PL; Langlotz, CP; Weinreb, JC
      Prostate Cancer: What is the future role for imaging?

      AMERICAN JOURNAL OF ROENTGENOLOGY
    11. Lee, AK; Schultz, D; Renshaw, AA; Richie, JP; D'Amico, AV
      Optimizing patient selection for prostate monotherapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    12. Hamdy, FC
      Prognostic and predictive factors in prostate cancer

      CANCER TREATMENT REVIEWS
    13. Engelbrecht, MR; Jager, GJ; Severens, JL
      Patient selection for magnetic resonance imaging of prostate cancer

      EUROPEAN UROLOGY
    14. Hoznek, A; Salomon, L; Olsson, LE; Antiphon, P; Saint, F; Cicco, A; Chopin, D; Abbou, CC
      Laparoscopic radical prostatectomy - The Creteil experience

      EUROPEAN UROLOGY
    15. Medica, M; Giglio, M; Germinale, F; Timossi, L; Romagnoli, A; Bertolotto, F; Carmignani, G
      Roach's mathematical equations in predicting pathological stage in men with clinically localized prostate cancer

      TUMORI
    16. Narain, V; Bianco, FJ; Grignon, DJ; Sakr, WA; Pontes, JE; Wood, DP
      How accurately does prostate biopsy Gleason score predict pathologic findings and disease free survival?

      PROSTATE
    17. Haese, A; Graefen, M; Steuber, T; Becker, C; Pettersson, K; Piironen, T; Noldus, J; Huland, H; Lilja, H
      Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml

      PROSTATE
    18. Straub, B; Muller, M; Krause, H; Goessl, C; Schrader, M; Heicappell, R; Miller, K
      Molecular staging of surgical margins after radical prostatectomy by detection of telomerase activity

      PROSTATE
    19. Sinha, AA; Quast, BJ; Wilson, MJ; Fernandes, ET; Reddy, PK; Ewing, SL; Sloane, BF; Gleason, DF
      Ratio of cathepsin B to stefin A identifies heterogeneity within gleason histologic scores for human prostate cancer

      PROSTATE
    20. Schatzl, G; Madersbacher, S; Thurridl, T; Waldmuller, J; Kramer, G; Haitel, A; Marberger, M
      High-grade prostate cancer is associated with low serum testosterone levels

      PROSTATE
    21. Arai, Y; Okubo, K; Terada, N; Matsuta, Y; Egawa, S; Kuwao, S; Ogura, K
      Volume-weighted mean nuclear volume predicts tumor biology of clinically organ-confined prostate cancer

      PROSTATE
    22. Miller, GJ; Torkko, KC
      Natural history of prostate cancer - Epidemiologic considerations

      EPIDEMIOLOGIC REVIEWS
    23. Link, RE; Morton, RA
      Indications for pelvic lymphadenectomy in prostate cancer

      UROLOGIC CLINICS OF NORTH AMERICA
    24. Cheung, R; Altschuler, MD; D'Amico, AV; Malkowicz, SB; Wein, AJ; Whittington, R
      Using the receiver operating characteristic curve to select pretreatment and pathologic predictors for early and late postprostatectomy PSA failure

      UROLOGY
    25. Roberts, WW; Bergstralh, EJ; Blute, ML; Slezak, JM; Carducci, M; Han, M; Epstein, JI; Eisenberger, MA; Walsh, PC; Partin, AW
      Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy

      UROLOGY
    26. Straub, B; Muller, M; Krause, H; Goessl, C; Schrader, M; Heicappell, R; Miller, K
      Reverse transcriptase-polymerase chain reaction for prostate-specific antigen in the molecular staging of pelvic surgical margins after radical prostatectomy

      UROLOGY
    27. Carroll, P; Coley, C; McLeod, D; Schellhammer, P; Sweat, G; Wasson, J; Zietman, A; Thompson, I
      Prostate-specific antigen best practice policy - part II: Prostate cancer staging and post-treatment follow-up

      UROLOGY
    28. Zhou, M; Hayasaka, S; Taylor, JMG; Shah, R; Proverbs-Singh, T; Manley, S; Rubin, MA
      Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy

      JOURNAL OF UROLOGY
    29. Walsh, PC
      Re: High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized cancer

      JOURNAL OF UROLOGY
    30. Borque, A; Sanz, G; Allepuz, C; Plaza, L; Gil, P; Rioja, LA
      The use of neural networks and logistic regression analysis for predictingpathological stage in men undergoing radical prostatectomy: A population based study

      JOURNAL OF UROLOGY
    31. Moul, JW; Connelly, RR; Lubeck, DP; Bauer, JJ; Sun, L; Flanders, SC; Grossfeld, GD; Carroll, PR
      Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the center for prostate disease research and cancer of the prostate strategic urologic research endeavor databases

      JOURNAL OF UROLOGY
    32. Noguchi, M; Stamey, TA; McNeal, JE; Yemoto, CM
      Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: Lack of prediction of tumor significance for men with nonpalpable prostate cancer

      JOURNAL OF UROLOGY
    33. Ross, PL; Scardino, PT; Kattan, MW
      Catalog of prostate cancer nomograms

      JOURNAL OF UROLOGY
    34. Grossfeld, GD; Chang, JJ; Broering, JM; Li, JP; Lubeck, DP; Flanders, SC; Carroll, PR
      Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor database

      JOURNAL OF UROLOGY
    35. Paquette, EL; Connelly, RR; Sesterhenn, IA; Zhang, W; Sun, L; Paquette, LR; Greenspan, R; McLeod, DG; Moul, JW
      Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen era - Implications for screening a high-risk group for prostate carcinoma

      CANCER
    36. Montie, JE; Wei, JT
      Artificial neural networks for prostate carcinoma risk assessment - An overview

      CANCER
    37. Ziada, AM; Lisle, TC; Snow, PB; Levine, RF; Miller, G; Crawford, ED
      Impact of different variables on the outcome of patients with clinically confined prostate carcinoma - Prediction of pathologic stage and biochemicalfailure using an artificial neural network

      CANCER
    38. Sebo, TJ; Cheville, JC; Riehle, DL; Lohse, CM; Pankratz, VS; Myers, RP; Blute, ML; Zincke, H
      Predicting prostate carcinoma volume and stage at radical prostatectomy byassessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen - A report of 454 cases

      CANCER
    39. Dunsmuir, WD; Gillett, CE; Meyer, LC; Young, MP; Corbishley, C; Eeles, RA; Kirby, RS
      Molecular markers for predicting prostate cancer stage and survival

      BJU INTERNATIONAL
    40. Shigeno, K; Igawa, M; Shiina, H; Wada, H; Yoneda, T
      The role of colour Doppler ultrasonography in detecting prostate cancer

      BJU INTERNATIONAL
    41. Engelbrecht, MRW; Barentsz, JO; Jager, GJ; van der Graaf, M; Heerschap, A; Sedelaar, JPM; Aarnink, RG; de la Rosette, JJMCH
      Prostate cancer staging using imaging

      BJU INTERNATIONAL
    42. Neulander, EZ; Duncan, RC; Tiguert, R; Posey, JT; Soloway, MS
      Deferred treatment of localized prostate cancer in the elderly: the impactof the age and stage at the time of diagnosis on the treatment decision

      BJU INTERNATIONAL
    43. D'Amico, AV; Whittington, R; Malkowicz, SB; Schultz, D; Silver, B; Henry, L; Hurwitz, M; Kaplan, I; Beard, CJ; Tomaszewski, JE; Renshaw, AA; Wein, A; Richie, JP
      Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancer

      PROSTATE CANCER AND PROSTATIC DISEASES
    44. Potters, L; Cha, C; Ashley, R; Freeman, K; Waldbaum, R; Wang, XH; Leibel, S
      The role of external beam irradiation in patients undergoing prostate brachytherapy

      UROLOGIC ONCOLOGY
    45. Kakehi, Y; Kamoto, T; Okuno, H; Terai, A; Terachi, T; Ogawa, O
      Per-operative frozen section examination of pelvic nodes is unnecessary for the majority of clinically localized prostate cancers in the prostate-specific antigen era

      INTERNATIONAL JOURNAL OF UROLOGY
    46. Russo, P
      Salvage radical prostatectomy after radiation therapy and brachytherapy

      JOURNAL OF ENDOUROLOGY
    47. Thompson, IM
      Counseling patients with newly diagnosed prostate cancer

      ONCOLOGY-NEW YORK
    48. Kattan, MW; Zelefsky, MJ; Kupelian, PA; Scardino, PT; Fuks, Z; Leibel, SA
      Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer

      JOURNAL OF CLINICAL ONCOLOGY
    49. Reckwitz, T; Potter, SR; Partin, AW
      Prediction of locoregional extension and metastatic disease in prostate cancer: a review

      WORLD JOURNAL OF UROLOGY
    50. Cornud, F; Hamida, K; Flam, T; Helenon, O; Chretien, Y; Thiounn, N; Correas, JM; Casanova, JM; Moreau, JF
      Endorectal color Doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: Correlation with radical prostatectomy findings

      AMERICAN JOURNAL OF ROENTGENOLOGY
    51. Sohn, JH; Kim, DH; Choi, NG; Park, YE; Ro, JY
      Caspase-3/CPP32 immunoreactivity and its correlation with frequency of apoptotic bodies in human prostatic carcinomas and benign nodular hyperplasias

      HISTOPATHOLOGY
    52. Koksal, IT; Ozcan, F; Kadioglu, TC; Esen, T; Kilicaslan, I; Tunc, M
      Discrepancy between Gleason scores of biopsy and radical prostatectomy specimens

      EUROPEAN UROLOGY
    53. Okegawa, T; Noda, H; Kato, M; Miyata, A; Nutahara, K; Higashihara, E
      Value of reverse transcription polymerase chain reaction assay in pathological stage T3N0 prostate cancer

      PROSTATE
    54. Ikonen, S; Karkkainen, P; Kivisaari, L; Salo, JO; Taari, K; Vehmas, T; Tervahartiala, P; Rannikko, S
      Magnetic resonance imaging of prostatic cancer: Does detection vary between high and low gleason score tumors?

      PROSTATE
    55. Stravodimos, K; Constantinides, C; Manousakas, T; Pavlaki, C; Pantazopoulos, D; Giannopoulos, A; Dimopoulos, C
      Immunohistochemical expression of transforming growth factor beta 1 and nm-23 H1 antioncogene in prostate cancer: Divergent correlation with clinicopathological parameters

      ANTICANCER RESEARCH
    56. Ash, D; Flynn, A; Battermann, J; de Reijke, T; Lavagnini, P; Blank, L
      ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer

      RADIOTHERAPY AND ONCOLOGY
    57. Rubin, MA; Dunn, R; Kambham, N; Misick, CP; O'Toole, KM
      Should a Gleason score be assigned to a minute focus of carcinoma on prostate biopsy?

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    58. Fergany, A; Kupelian, PA; Levin, HS; Zippe, CD; Reddy, C; Klein, EA
      No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients

      UROLOGY
    59. Jager, GJ; Severens, JL; Thornbury, JR; de la Rosette, JJMCH; Ruijs, SHJ; Barentsz, JO
      Prostate cancer staging: Should MR imaging be used? - A decision analytic approach

      RADIOLOGY
    60. Presti, JC
      Prostate cancer: Assessment of risk using digital rectal, examination, tumor grade, prostate-specific antigen, and systematic biopsy

      RADIOLOGIC CLINICS OF NORTH AMERICA
    61. Gao, X; Mohideen, N; Flanigan, RC; Waters, WB; Wojcik, EM; Leman, CR
      The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: Implications for treatment selection

      JOURNAL OF UROLOGY
    62. Fujikawa, K; Matsui, Y; Kobayashi, T; Miura, K; Oka, H; Fukuzawa, S; Takeuchi, H
      Predicting pathological stage of localized prostate cancer using volume weighted mean nuclear volume

      JOURNAL OF UROLOGY
    63. Blute, ML; Bergstralh, EJ; Partin, AW; Walsh, PC; Kattan, MW; Scardino, PT; Montie, JE; Pearson, JD; Slezak, JM; Zincke, H
      Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer

      JOURNAL OF UROLOGY
    64. Meng, MV; Carroll, PR
      When is pelvic lymph node dissection necessary before radical prostatectomy? A decision analysis

      JOURNAL OF UROLOGY
    65. Fujikawa, K; Matsui, Y; Oka, H; Fukuzawa, S; Sasaki, M; Takeuchi, H
      The role of volume weighted mean nuclear volume in predicting the prognosis of patients with primary transitional cell carcinoma of the upper urinarytract: A report of 102 new cases

      JOURNAL OF UROLOGY
    66. Stamey, TA; Yemoto, CM; McNeal, JE; Sigal, BM; Johnstone, IM
      Prostate cancer is highly predictable: A prognostic equation based on all morphological variables in radical prostatectomy specimens

      JOURNAL OF UROLOGY
    67. Halmos, G; Arencibia, JM; Schally, AV; Davis, R; Bostwick, DG
      High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers

      JOURNAL OF UROLOGY
    68. King, CR
      Patterns of prostate cancer biopsy grading: Trends and clinical implications

      INTERNATIONAL JOURNAL OF CANCER
    69. King, CR; Long, JP
      Prostate biopsy grading errors: A sampling problem?

      INTERNATIONAL JOURNAL OF CANCER
    70. Fujikawa, K; Matsui, Y; Oka, H; Fukuzawa, S; Sasaki, H; Takeuchi, H
      Prognosis of primary testicular seminoma: A report on 57 new cases

      CANCER RESEARCH
    71. Anderson, PR; Hanlon, AL; Horwitz, E; Pinover, W; Hanks, GE
      Outcome and predictive factors for patients with Gleason score 7 prostate carcinoma treated with three-dimensional conformal external beam radiation therapy

      CANCER
    72. Crawford, ED; Batuello, JT; Snow, P; Gamito, EJ; McLeod, DG; Partin, AW; Stone, N; Montie, J; Stock, R; Lynch, J; Brandt, J
      The use of artificial intelligence technology to predict lymph node spreadin men with clinically localized prostate carcinoma

      CANCER
    73. D'Amico, AV; Whittington, R; Malkowicz, SB; Schultz, D; Tomaszewski, JE; Wein, A
      Prostate specific antigen outcome based on the extent of extracapsular extension and margin status in patients with seminal vesicle negative prostatecarcinoma of Gleason score <= 7

      CANCER
    74. Montie, JE; Wei, JT
      Artificial neural networks for prostate carcinoma risk assessment - An overview

      CANCER
    75. Bostwick, DG; Grignon, DJ; Hammond, MEH; Amin, MB; Cohen, M; Crawford, D; Gospadarowicz, M; Kaplan, RS; Miller, DS; Montironi, R; Pajak, TF; Pollack, A; Srigley, JR; Yarbro, JW
      Prognostic factors in prostate cancer - College of American Pathologists Consensus Statement 1999

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    76. Thorson, P; Humphrey, PA
      Minimal adenocarcinoma in prostate needle biopsy tissue

      AJCP. American journal of clinical pathology
    77. Shackley, DC; Irving, SO; Brough, WA; O'Reilly, PH
      Staging laparoscopic pelvic lymphadenectomy in prostate cancer

      BJU INTERNATIONAL
    78. Gohji, K; Okamoto, M; Takenaka, A; Nomi, M; Fujii, A
      Predicting the extent of prostate cancer using the combination of systematic biopsy and serum prostate-specific antigen in Japanese men

      BJU INTERNATIONAL
    79. Parker, CC; Husband, J; Dearnaley, DP
      Lymph node staging in clinically localized prostate cancer

      PROSTATE CANCER AND PROSTATIC DISEASES
    80. Fornara, P; Doehn, C; Jocham, D
      Role of laparoscopy in the lymph-node staging of urological malignancies

      MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES
    81. Civantos, F; Sadek, S; Obek, C; Lai, SH; Soloway, M
      Neoadjuvant hormonal therapy prior to radical prostatectomy

      MOLECULAR UROLOGY
    82. Lisle, TC; Ziada, AM; Andros, EA; Crawford, ED
      Neoadjuvant hormonal therapy in stage C adenocarcinoma of the prostate andincidence of biochemical recurrence

      MOLECULAR UROLOGY
    83. Bai, XZ; Masters, JRW; O'Donoghue, N; Kirby, R; Pan, LX; Young, M; Stafford, M; Parkinson, MC
      Prognostic markers in clinically localised prostate cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    84. Fujikawa, K; Aoyama, T; Itoh, T; Nishio, Y; Miyakawa, M; Sasaki, M
      The role of volume-weighted mean nuclear volume in predicting disease outcome in patients with stage M1 prostate cancer

      APMIS
    85. Vicini, FA; Kestin, LL; Stromberg, JS; Martinez, AA
      Brachytherapy boost techniques for locally advanced prostate cancer

      ONCOLOGY-NEW YORK
    86. Jhaveri, FM; Klein, EA; Kupelian, PA; Zippe, C; Levin, HS
      Declining rates of extracapsular extension after radical prostatectomy: Evidence for continued stage migration

      JOURNAL OF CLINICAL ONCOLOGY
    87. Lin, K; Szabo, Z; Chin, BB; Civelek, AC
      The value of a baseline bone scan in patients with newly diagnosed prostate cancer

      CLINICAL NUCLEAR MEDICINE
    88. D'Amico, AV; Renshaw, AA; Schultz, D; Rocha, S; Richie, JP
      The impact of the biopsy gleason score on PSA outcome for prostate cancer patients with PSA <= 10 ng/ml and T1C,2A: Implications for patient selection for prostate-only therapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    89. Stock, RG; Lo, YC; Gaildon, M; Stone, NN
      Does prostate brachytherapy treat the seminal vesicles? A dose-volume histogram analysis of seminal vesicles in patients undergoing combined Pd-103 prostate implantation and external beam irradiation

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    90. Nag, S; Beyer, D; Friedland, J; Grimm, P; Nath, R
      American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    91. D'Amico, AV; Davis, A; Vargas, SO; Renshaw, AA; Jiroutek, M; Richie, JP
      Defining the implant treatment volume for patients with low risk prostate cancer: Does the anterior base need to be treated?

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    92. Jakse, G; Brehmer, B; Wolff, JM; Aretz, R; Handt, S
      Radical perineal prostatectomy without lymphadenectomy in patients with cT1+2, G1+2, PSA <= 10 ng/ml prostate cancer

      UROLOGE-AUSGABE A
    93. Masuda, M; Iki, M; Noguchi, S; Mikata, K; Kubota, Y; Harada, M; Hosaka, M
      The worst histologic elements predict prognosis in moderately-differentiated prostate cancer patients with androgen-withdrawal endocrine therapy

      EUROPEAN UROLOGY
    94. Salomon, L; Colombel, M; Patard, JJ; Lefrere-Belda, MA; Bellot, J; Chopin, D; Abbou, CC
      Value of ultrasound-guided systematic sextant biopsies in prostate tumor mapping

      EUROPEAN UROLOGY
    95. Altwein, JE
      Therapeutic options in locally defined or advanced prostate cancer

      EUROPEAN UROLOGY
    96. Ross, JS; Sheehan, CE; Ambros, RA; Nazeer, T; Jennings, TA; Kaufman, RP; Fisher, HAG; Rifkin, MD; Kallakury, BVS
      Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    97. Cheng, L; Cheville, JC; Bostwick, DG
      Diagnosis of prostate cancer in needle biopsies after radiation therapy

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    98. Pollack, A; Zagars, GK; Rosen, II
      Prostate cancer treatment with radiotherapy: Maturing methods that minimize morbidity

      SEMINARS IN ONCOLOGY
    99. Manyak, MJ; Hinkle, GH; Olsen, JO; Chiaccherini, RP; Partin, AW; Piantadosi, S; Burgers, JK; Texter, JH; Neal, CE; Libertino, JA; Wright, GL; Maguire, RT
      Immunoscintigraphy with indium-111-capromab pendetide: Evaluation before definitive therapy in patients with prostate cancer

      UROLOGY
    100. Potter, SR; Miller, MC; Mangold, LA; Jones, KA; Epstein, JI; Veltri, RW; Partin, AW
      Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy

      UROLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/11/20 alle ore 06:36:03